Showing results (311-320 of 331) with videos related to

Sort By:
Pageof 34
Cancer|June 1, 1996
Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935P Kumar, J Herndon, M Langer, et al.
Archives of Disease in Childhood|February 1, 1994
Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal periodL T Weaver, M R Green, K Nicholson, et al.
Archives of Disease in Childhood|April 1, 1993
Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural historyM R Green, L T Weaver, A F Heeley, et al.
Seminars in Oncology|December 10, 1999
Single-agent gemcitabine and gemcitabine/irinotecan combination (irimogem) in non-small cell lung cancerC M Rocha Lima, J R Eckardt, S S Leong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234N J Vogelzang, J E Herndon, A Miller, et al.
Cell|December 9, 1998
Dissecting the regulatory circuitry of a eukaryotic genomeF C Holstege, E G Jennings, J J Wyrick, et al.
Nature|July 21, 1994
Nuclear protein CBP is a coactivator for the transcription factor CREBR P Kwok, J R Lundblad, J C Chrivia, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin geneB Guo, F Aslam, A J van Wijnen, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 1996
A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer: a cancer and leukemia group B studyE P Mitchell, M C Perry, S D Luikart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicityM A Socinski, C Zhang, J E Herndon, et al.
Pageof 34